| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | NEUTRAL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 3.79▲ | 3.80▼ | 3.81▼ | 3.87▼ | 3.67▲ |
| MA10 | 3.83▼ | 3.82▼ | 3.82▼ | 3.93▼ | 3.55▲ |
| MA20 | 3.80▼ | 3.81▼ | 3.84▼ | 3.59▲ | 4.39▼ |
| MA50 | 3.87▼ | 3.78▲ | 3.65▲ | 3.68▲ | 3.69▲ |
| MA100 | 3.56▲ | 3.50▲ | 3.46▲ | 4.59▼ | 26.58▼ |
| MA200 | 3.40▲ | 3.54▲ | 3.83▼ | 4.08▼ | 189.10▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.007▼ | -0.016▼ | -0.026▼ | 0.048▲ | 0.070▲ |
| RSI | 47.707▼ | 48.145▼ | 49.280▼ | 52.313▲ | 44.190▼ |
| STOCH | 41.760 | 54.427 | 54.427 | 43.588 | 33.435 |
| WILL %R | -59.375 | -59.375 | -59.375 | -52.824 | -64.776 |
| CCI | -25.754 | -25.950 | -28.081 | 10.005 | -14.052 |
|
Thursday, March 19, 2026 06:14 AM
COPENHAGEN, Denmark, March 19, 2026 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company developing novel vaccines with its ...
|
|
Tuesday, March 17, 2026 01:45 PM
Two abstracts accepted for presentationOne abstract on new additional biomarker and immunogenicity data for personalized cancer vaccine ...
|
|
Wednesday, March 11, 2026 10:11 PM
Detailed price information for Evaxion A/S ADR (EVAX-Q) from The Globe and Mail including charting and trades.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 24/03/26 | 3.73 | 3.79 | 3.73 | 3.79 | 9,706 |
| 23/03/26 | 4.00 | 4.0399 | 3.6755 | 3.88 | 24,158 |
| 20/03/26 | 4.00 | 4.0909 | 3.77 | 3.91 | 21,350 |
| 19/03/26 | 3.75 | 4.00 | 3.5917 | 4.00 | 15,664 |
| 18/03/26 | 3.89 | 4.02 | 3.66 | 3.78 | 51,100 |
| 17/03/26 | 3.83 | 3.966 | 3.76 | 3.83 | 25,800 |
| 16/03/26 | 4.045 | 4.045 | 3.59 | 3.76 | 55,025 |
| 13/03/26 | 4.25 | 4.641 | 4.09 | 4.26 | 86,900 |
| 12/03/26 | 3.90 | 4.39 | 3.84 | 4.18 | 60,484 |
| 11/03/26 | 3.60 | 3.92 | 3.5068 | 3.87 | 43,469 |
|
|
||||
|
|
||||
|
|